Biocompatibility of hydroxyapatite scaffolds processed by lithography-based additive manufacturing

Bone tissue engineering requires materials that support cell growth and mechanical stability. Hydroxyapatite is a known candidate due to its similarity to bone mineral. However, traditional fabrication methods limit control over scaffold architecture. Lithography-based additive manufacturing offers precise control over porosity and structure. This technique allows for the creation of complex geometries that mimic natural bone. Prior research has shown that scaffold porosity and density influence cell behavior. Yet, the biocompatibility of lithography-based hydroxyapatite scaffolds remains underexplored. This gap motivated the current investigation into their suitability for tissue engineering. The study aimed to bridge this knowledge gap by evaluating both mechanical and biological properties.

This study aimed to assess the biocompatibility of hydroxyapatite scaffolds produced via lithography-based additive manufacturing. The goal was to determine whether these scaffolds support cell attachment and proliferation. Researchers focused on evaluating mechanical properties such as density and compressive strength. They also sought to compare the scaffolds with conventionally sintered hydroxyapatite. The study tested the hypothesis that lithography-based scaffolds could offer improved biocompatibility. By using pre-osteoblast cells, the team aimed to simulate bone regeneration conditions. The research also aimed to confirm that these scaffolds do not exhibit cytotoxic effects. The ultimate purpose was to establish the feasibility of using this method in tissue engineering.

Researchers used a digital light processing system to fabricate hydroxyapatite scaffolds. The system allowed for precise control over scaffold architecture and porosity. Scaffolds were produced at a laboratory scale using lithography-based additive manufacturing. The team measured porosity, density, and compressive strength of the fabricated structures. Cell-culturing tests were conducted to assess biocompatibility. Pre-osteoblast cells (MC3T3-E1) were used to evaluate cell attachment and proliferation. Cytotoxicity was assessed through direct contact and viability tests. The scaffolds were compared to conventionally sintered hydroxyapatite for performance evaluation.

The hydroxyapatite scaffolds achieved 77% porosity with 91% theoretical density. Compressive strength was measured at 0.36 MPa, indicating structural stability. No cytotoxic effects were observed during direct contact tests. Cell viability reached 95.1%, suggesting strong biocompatibility. After 14 days, pre-osteoblasts adhered to the scaffolds and began proliferating. The scaffolds supported cell differentiation, a key requirement for tissue engineering. These results outperformed conventional sintering methods in terms of biocompatibility. The study confirmed the potential of lithography-based manufacturing for bone scaffolds.

The study demonstrated that lithography-based additive manufacturing can produce hydroxyapatite scaffolds with favorable properties. The scaffolds exhibited high porosity and density while maintaining structural integrity. Biocompatibility tests showed no cytotoxic effects and high cell viability. The scaffolds supported pre-osteoblast attachment and differentiation over 14 days. These findings suggest that the method is suitable for bone tissue engineering applications. The results align with the authors' hypothesis that this technique enhances scaffold performance. The study did not propose future directions or drug targets. The authors concluded that the method is a viable option for producing biocompatible scaffolds.